I
t has long been believed that the generation of high-affinity neutralizing antibodies is critical for antiviral humoral immunity. The production of highaffinity antibodies depends on the formation of germinal centers (GC) in lymph nodes and a subset of T cells called follicular helper T (T FH ) cells in GCs. However, we discovered that T helper 1 (T H 1) cells induce low-affinity IgG2 antibodies sufficient for preventing influenza A virus (IAV) infection. 1 Influenza pandemics have become a serious public health concern in recent years. The emergence of the pandemic H1N1 IAV in 2009 reminds us of the constant threat of zoonotic IAV, and H5N1 is a highly virulent avian IAV that causes high mortality. Vaccination is critical for preventing the spread of the influenza virus in the population. However, there is no vaccine that offers adequate protection against emerging flu viruses. Thus, a better understanding of the mechanism of neutralizing antibody induction during influenza infection is essential to develop alternative vaccines against emerging pandemic influenza. In general, antibodies mediate the protective response against viral products, including the envelope glycoprotein hemagglutinin (HA). IgG2 is the predominant protective subclass of antibody isoforms, although IgG1 and IgG3 also contribute. 2, 3 The pathogen-specific IgG2 response is known to be differentially regulated from the IgG1 response, which is the major antibody response to soluble antigens. However, the mechanism underlying the generation of IgG2 specific for IAV remains unclear.
Naive CD4 + T cells differentiate into distinct helper T-cell subsets that regulate adaptive immunity. The intrinsic T-cell program enables the dominant propagation of selected T-cell subsets in a particular environment, which is shaped by encounters with pathogens, including viral and bacterial infections and inflammation. Acute IAV infection elicited T FH and T H 1 lineages equally. 4 T H 1 responses are characterized by the release of high levels of IFN-γ and result in the generation of cytotoxic T lymphocytes (CTLs). T FH cells are a specialized subset of helper T cells that stimulate B cells to produce high-affinity antibodies.
The differentiation of T H 1 and T FH cells is exclusively controlled by the Kruppel-like factor 2 (KLF2)-Forkhead box protein O1 (FOXO1) axis and expression of the zinc finger transcriptional repressor B-cell lymphoma 6 (BCL--6), respectively. The KLF2-FOXO1 axis induces expression of several T H 1 signature genes, including C-C chemokine receptor type 6, Epstein-Barr virusinduced G-protein-coupled receptor 2, P-selectin glycoprotein ligand 1, C-C chemokine receptor type 7, and sphingosine-1-phosphate receptor 1, and antagonizes the expression of C-X-C chemokine receptor type 5 (CXCR5), 5 which attracts T FH cells toward the C-X-C chemokine ligand-13 present in the B-cell follicle. In contrast, T FH cells are characterized by expression of BCL-6, CXCR5 and inducible T-cell co-stimulator (ICOS). 6 Bcl6 antagonizes the T H 1 program through its direct binding to the Tbx21 gene, which encodes the T H 1 master regulator T-bet. 7 ICOS signaling is needed to antagonize the KLF2-FOXO1 axis and potentiate IL-21 production. 8 T FH cells are a specialized helper T-cell subset that interacts with cognate B cells to induce formation of GC, 6 which are required for somatic hyper-mutation (SHM) and selection of high-affinity antibodies. 9, 10 The majority of T FH cells secrete IL-4 and IL-21 and play a role in T-cell-dependent B-cell responses mainly by contributing to class-switch recombination of IgG1 and IgE. [11] [12] [13] [14] However, IgG2 is the major class of IgG antibody responsible for viral protection. It remains unclear which helper T cells regulate the IgG2 response and what the functional consequences of IgG2-mediated protection against IAV infection may be. We addressed these questions regarding the roles of T FH and T H 1 cells in humoral responses against IAV infection by utilizing mice lacking T FH or GC due to the deletion of Bcl6 in either CD4 T cells (Bcl6 f/f cd4-cre; Bcl6 ΔT ) or B cells (Bcl6 f/f mb1-cre; Bcl6 ΔB ). 1 We found differing requirements for T FH and T H 1 cells in the IgG1 and IgG2 responses induced by systemic immunization with inactivated IAV. 1 Surprisingly, Bcl6-sufficient and -deficient mice were equally effective against either pandemic H1N1 and highly virulent H5N1 virus when the mice were vaccinated with the inactivated IAV. This immunization protocol induced a virusspecific CTL response, but vaccinated Cd8a-deficient mice survived as long as wild-type mice, which indicated that the CTL response is not required for the protection.
Bcl6 deficiency in T or B cells resulted in a massive reduction of IgG1 antibodies; however, substantial amounts of virus-specific IgG2 were found in the absence of T FH , and the antibodies protected non-vaccinated mice from the lethal IAV infection. Therefore, the generation of an IgG2 response and class switching would be reduced in the T FH program. Moreover, the data from double knockout Bcl6 and Ifng mice and Ifng-deficient mice indicate that IFN-γ is a critical cytokine for IgG2 responses. We searched for the source of IFN-γ-secreting CD4 T cells preferentially expressed CXCR3, and we found two major IFN-γ expression subsets; CXCR3 + CXCR5 + T FH cells were the minor population, and CXCR3 + CXCR5 − T H 1 cells were the major population induced by the vaccination. Interestingly, a proportion of the IFN-γ expressing T H 1 cells produce IL-21, which has a role in the GC-independent HA-specific IgG2 antibody response. Adaptive transfer of CXCR3 + CXCR5 − T H 1 cells from vaccinated mice indicated the requirement of virus-specific IgG2 responses and conferred significant protection. Under these circumstances, large numbers of T H 1 cells localized within B-cell follicles without forming GC. It has been reported that helper T cells are not entirely diminished in the absence of CXCR5. [15] [16] [17] Other homing receptors (for example, sphingosine-1-phosphate receptor 2) 18 may contribute the migration of T H 1 cells into follicles.
GC are crucial structures for SHM and selection of high-affinity antibodies. Comprehensive sequencing analysis of the Ighg gene of HA-specific plasmablasts revealed that the absence of GC alters the repertoire of HA-reactive B-cell receptors and decreases the mutation rate in the complementarity-determining region of the Ighg gene as consequences of the impairment of SHM. The actual affinity of IgG2 from Bcl6-deficient mice against HA was decreased. Thus, high-affinity antibodies are not entirely necessary for protective IgG2 responses in IAV vaccination.
In conclusion, during inactivated IAV vaccination,
antigen-specific CD4 + T cells expand, and two distinct sets of antigen-specific IFN-γ-expressing T H cell subsets, CXCR3 + CXCR5 + T FH cells and CXCR3 + CXCR5 − T H 1 cells, develop in the spleen and draining lymph nodes. CXCR3 + CXCR5 + T FH cells generate high-affinity IgG2 responses in GC, while CXCR3 + T H 1 cells dominate in the response to IAV and are responsible for low-affinity IgG2 responses in the inner follicle ( Figure 1 ). The dominance of T FH -or GC-independent low-affinity IgG2 antibodies still confers effective protection against viral infection with H5N1 and H1N1 IAV. In this context, IFN-γ and IL-21 from CXCR3 + CXCR5 − T H 1 cells were critical for the GCindependent IgG2 antibody responses. Our findings provide new insights indicating that low-affinity IgG2 antibodies may be beneficial, through a dynamic process of mutation and selection, in establishing a new antibody repertoire, which is then optimally adapted to recall upon challenge.
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